{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:26:49Z","timestamp":1771007209766,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":898,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Nycomed Deutschland GmbH"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.rmed.2010.09.016","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T04:39:34Z","timestamp":1289363974000},"page":"186-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy and safety of ciclesonide in the treatment of 24,037 asthmatic patients in routine medical care"],"prefix":"10.1016","volume":"105","author":[{"given":"Claus F.","family":"Vogelmeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Sander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas D.","family":"Bethke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2010.09.016_bib1","author":"Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA)"},{"issue":"4","key":"10.1016\/j.rmed.2010.09.016_bib2","first-page":"358","article-title":"Addressing steroid phobia: improving the risk-benefit ratio with new agents","volume":"29","author":"Skoner","year":"2008","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.rmed.2010.09.016_bib3","first-page":"5S","article-title":"Developing the ideal inhaled corticosteroid","volume":"130","author":"Cerasoli","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2010.09.016_bib4","first-page":"243","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of inhaled ciclesonide","volume":"48","author":"Nave","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.rmed.2010.09.016_bib5","first-page":"782","article-title":"Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide","volume":"47","author":"Derendorf","year":"2007","journal-title":"J Clin Pharmacol"},{"issue":"90","key":"10.1016\/j.rmed.2010.09.016_bib6","first-page":"62","article-title":"Relevant pharmacokinetic parameters for determining efficacy and safety in inhaled corticosteroids","volume":"13","author":"Derendorf","year":"2004","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmed.2010.09.016_bib7","first-page":"117","article-title":"Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers","volume":"19","author":"Leach","year":"2006","journal-title":"J Aerosol Med"},{"issue":"11","key":"10.1016\/j.rmed.2010.09.016_bib8","first-page":"1033","article-title":"Ciclesonide","volume":"26","author":"Mealy","year":"2001","journal-title":"Drugs Future"},{"issue":"90","key":"10.1016\/j.rmed.2010.09.016_bib9","first-page":"60","article-title":"Preclinical pharmacology of ciclesonide","volume":"13","author":"Belvisi","year":"2004","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmed.2010.09.016_bib10","first-page":"330","article-title":"Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma","volume":"60","author":"Chapman","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2010.09.016_bib11","first-page":"1083","article-title":"Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening","volume":"17","author":"Postma","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.09.016_bib12","first-page":"1275","article-title":"Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma","volume":"99","author":"Langdon","year":"2005","journal-title":"Respir Med"},{"issue":"Suppl. 38","key":"10.1016\/j.rmed.2010.09.016_bib13","article-title":"Treatment of moderate to severe asthma with ciclesonide: a long-term investigation over 52 weeks","volume":"20","author":"O'Connor","year":"2002","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.rmed.2010.09.016_bib14","first-page":"1206","article-title":"Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma","volume":"116","author":"Pearlman","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2010.09.016_bib15","first-page":"944","article-title":"Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device","volume":"56","author":"Dubus","year":"2001","journal-title":"Allergy"},{"issue":"90","key":"10.1016\/j.rmed.2010.09.016_bib16","first-page":"69","article-title":"Safety and efficacy of inhaled corticosteroids","volume":"13","author":"Bousquet","year":"2004","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.rmed.2010.09.016_bib17","first-page":"328","article-title":"Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway-responsiveness to adenosine 5'monophosphate in asthmatic patients","volume":"18","author":"Derom","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.rmed.2010.09.016_bib18","first-page":"e1","article-title":"Ciclesonide Pediatric Growth Study Group. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma","volume":"121","author":"Skoner","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.rmed.2010.09.016_bib19","series-title":"Guidance for Industry \u2013 Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment","author":"US Department of Health and Human Services, Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER)","year":"2005"},{"key":"10.1016\/j.rmed.2010.09.016_bib20","series-title":"Guidelines for Good Pharmacoepidemiology Practice (GPP)","author":"International Society for PharmacoEpidemiology (ISPE)","year":"2009"},{"key":"10.1016\/j.rmed.2010.09.016_bib21","series-title":"Good Epidemiological Practice (GEP) \u2013 IEA Guidelines for proper conduct of epidemiological research","author":"International Epidemiological Association (IEA) European Federation","year":"2007"},{"key":"10.1016\/j.rmed.2010.09.016_bib22","series-title":"VFAEmpfehlungen zur Verbesserung der Qualit\u00e4t und Transparenz von nicht-interventionellen Studien. 31.01. 2007","author":"Verband Forschender Arzneimittelhersteller e.V","year":"2007"},{"issue":"6","key":"10.1016\/j.rmed.2010.09.016_bib23","first-page":"1433","article-title":"The Brussels Declaration: the need for change in asthma management","volume":"32","author":"Holgate","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2010.09.016_bib24","first-page":"74","article-title":"The AIR study: asthma in real life","volume":"4","author":"Price","year":"1999","journal-title":"Asthma J"},{"key":"10.1016\/j.rmed.2010.09.016_bib25","first-page":"721","article-title":"Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: a retrospective observational study","volume":"23","author":"Borderias","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rmed.2010.09.016_bib26","first-page":"3141","article-title":"An observational study of fixed dose combination fluticasone propionate\/salmeterol or fluticasone propionate alone on asthma-related outcomes","volume":"24","author":"Stanford","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rmed.2010.09.016_bib27","first-page":"47","article-title":"The national montelukast survey","volume":"115","author":"Barnes","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.rmed.2010.09.016_bib28","first-page":"644","article-title":"Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study","volume":"104","author":"Virchow","year":"2010","journal-title":"Respir Med"},{"issue":"Suppl. A","key":"10.1016\/j.rmed.2010.09.016_bib29","first-page":"17A","article-title":"Montelukast as add-on therapy with inhaled corticosteroids alone or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial)","volume":"16","author":"Keith","year":"2009","journal-title":"Can Respir J"},{"issue":"Suppl. A","key":"10.1016\/j.rmed.2010.09.016_bib30","first-page":"5A","article-title":"Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial)","volume":"16","author":"FitzGerald","year":"2009","journal-title":"Can Respir J"},{"key":"10.1016\/j.rmed.2010.09.016_bib31","first-page":"116","article-title":"High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study","volume":"123","author":"Thomas","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2010.09.016_bib32","year":"2009"},{"issue":"8","key":"10.1016\/j.rmed.2010.09.016_bib33","first-page":"663","article-title":"The revised CONSORT statement for reporting randomized trials: explanation and elaboration","volume":"134","author":"Altman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmed.2010.09.016_bib34","unstructured":"Summary of Product Characteristics. Alvesco\u00ae 80 \u03bcg and 160 \u03bcg; September 2009."},{"key":"10.1016\/j.rmed.2010.09.016_bib35","volume":"vol. 16","year":"2006"},{"key":"10.1016\/j.rmed.2010.09.016_bib36","first-page":"906","article-title":"A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma","volume":"28","author":"Hansel","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.rmed.2010.09.016_bib37","first-page":"1752","article-title":"Comparison of the efficacy of ciclesonide 160 \u03bcg QD and budesonide 200 \u03bcg BID in adults with persistent asthma: a phase III, randomized, doubly-dummy, open-label study","volume":"27","author":"Niphadkar","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.rmed.2010.09.016_bib38","first-page":"391","article-title":"Comparison of the efficacy and safety of ciclesonide 160 \u03bcg once daily vs. budesonide 400 \u03bcg once daily in children with asthma","volume":"18","author":"von Berg","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.rmed.2010.09.016_bib39","first-page":"214","article-title":"Efficacy and safety of ciclesonode once daily and fluticasone propionate twice daily in children with asthma","volume":"22","author":"Pedersen","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.rmed.2010.09.016_bib40","first-page":"304","article-title":"Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroids","volume":"30","author":"Berger","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.rmed.2010.09.016_bib41","first-page":"521","article-title":"Ciclesonide improves health-related quality of life in adults and adolescents with mild-to-moderate persistent asthma","volume":"29","author":"Nathan","year":"2008","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.rmed.2010.09.016_bib42","first-page":"555","article-title":"Similar efficacy of ciclesonide once daily versus fluticasone propionate twice daily in patients with persistent asthma","volume":"44","author":"Magnussen","year":"2007","journal-title":"J Asthma"},{"issue":"1","key":"10.1016\/j.rmed.2010.09.016_bib43","first-page":"19","article-title":"Determinants of under-reporting of adverse drug reactions: a systematic review","volume":"32","author":"Lopez-Gonzalez","year":"2009","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.rmed.2010.09.016_bib44","first-page":"385","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461111000421X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461111000421X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:02:11Z","timestamp":1760612531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461111000421X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S095461111000421X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2010.09.016","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of ciclesonide in the treatment of 24,037 asthmatic patients in routine medical care","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2010.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}